March 2021
The 91大神 School of Medicine (UMSOM) is participating in Moderna鈥檚 pediatric COVID-19 vaccine trial. The vaccine has already received emergency use authorization for patients as young as 17, and trials for children between the ages of 12 and 17 have been underway for months. This new trial will include children ages 6 months to 11 years.
The UMSOM Center for Vaccine Development and Global Health (CVD) hopes to begin enrollment in the next few weeks. To be placed on a waiting list for enrollment, contact the (), or call the center at 410-706-7926 between 8 a.m. and 4 p.m. You may also text 鈥淐VD鈥 to 52855.
Learn more about the Moderna pediatric COVID-19 vaccine study by following the links to any of these news outlets.
Search UMB News
There are no reported emergencies on campus at this time.
Sign up for UMB Alerts.
Sign up for UMB Alerts.